logo
Plus   Neg
Share
Email

Flex Pharma To Close FLX-787 Phase 2 Trials; To Assess Strategic Alternatives

Flex Pharma, Inc. (FLKS) announced that the company is ending its ongoing Phase 2 clinical trial investigations of FLX-787 in amyotrophic lateral sclerosis and Charcot-Marie-Tooth due to oral tolerability concerns observed in both studies, in a subset of patients being treated.

Flex Pharma announced the company will restructure its organization to reduce costs, including reducing its workforce by approximately 60 percent. The company's Board and its management are in alignment that the company's best path forward to preserve stockholder value is to focus its resources on assessing strategic alternatives, including the potential sale or merger of the company. The Board has established a Strategic Committee that will work with management to oversee the process.

The company said it will continue to operate with a reduced internal team that will focus efforts on assessing the potential of FLX-787 in dysphagia and operating the HOTSHOT consumer business while the strategic review is ongoing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The National Retail Federation or NRF said that conflicting economic data amid a resurgence in coronavirus cases has made it difficult to predict how steadily the U.S. economic recovery will continue. NRF Chief Economist Jack Kleinhenz noted that based on quarterly and monthly data, the U.S. economic recovery is continuing despite the elevated COVID-19 cases. Ford Motor Company (F) announced that Jim Hackett plans to retire as President and CEO. He will continue as a special advisor to the company through March of 2021. The company has named Jim Farley as new president and CEO. He will join the board of directors, effective Oct. 1. Farley joined Ford in... Google parent Alphabet Inc. has issued $5.75 billion in sustainability bonds, becoming the largest green or sustainability bonds issued by a company until now. This is part of a $10 billion debt offering. Alphabet said the proceeds will be used to fund projects that are environmentally or socially responsible.
Follow RTT